Such is the case for a positive allosteric modulator of the α1A-AR that was shown in pre-clinical studies to improve long-term synaptic plasticity and cognition, and clear β-amyloids in AD mouse models better than donepezil (i.e., Aricept) but without effects on blood pressure [34]. Here, PPIB is linked to amyloidosis.